Best Kinase Inhibitor for idiopathic pulmonary fibrosis
2 Kinase Inhibitor drugs indicated for idiopathic pulmonary fibrosis, ranked by our independent rating. The current highest-rated is ofev. Compare them with all treatments for idiopathic pulmonary fibrosis or the full Kinase Inhibitor class. Not medical advice — always consult a professional.
Top kinase inhibitor for idiopathic pulmonary fibrosis: 1. Ofev · 2. Nintedanib Esylate
| # | Drug | Rating | Type | Typical price | |
|---|---|---|---|---|---|
| 1 | Ofev | 70/100 | Prescription | — | View → |
| 2 | Nintedanib Esylate | Not yet rated | Prescription | — | View → |
Full ranking · 2 drugs
Frequently asked
- What is the best kinase inhibitor for idiopathic pulmonary fibrosis?
- By our independent rating, ofev currently ranks highest among Kinase Inhibitor drugs used for idiopathic pulmonary fibrosis. Ratings are based on FDA regulatory (recall-safety) data — always consult a professional.
- Which kinase inhibitor drugs treat idiopathic pulmonary fibrosis?
- pharmaranks lists 2 Kinase Inhibitor products indicated for idiopathic pulmonary fibrosis, per FDA drug-label data — each independently rated and ranked above.
- How are these ranked?
- By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.